Cell News and Research

RSS

Scientists identify stress receptor that stimulates growth and migration of cancer cells

It's a common belief that there's a link between chronic stress and an increased risk of cancer. In new research published online by the International Journal of Cancer, scientists at The University of Western Ontario have taken a step toward confirming that belief.

22 Sep 2011

African Americans more likely than Caucasians to develop and die from lung cancer

Lung cancer, the leading cause of cancer death in the U.S., takes a particularly heavy toll on African Americans. Despite their lower smoking rates, African Americans are more likely than Caucasians to develop and die from lung cancer.

21 Sep 2011

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Racial and ethnic minorities are more likely to develop cancer and die from it than the general U.S. population. However, as the next generation of cancer medicines are being evaluated, only 17 percent of clinical trial participants are, in fact, minorities.

21 Sep 2011

Researchers show how the body rids itself of damage when needed to reproduce and create new life

Although the body is constantly replacing cells and cell constituents, damage and imperfections accumulate over time. Cleanup efforts are saved for when it really matters. Researchers from the University of Gothenburg, Sweden, are able to show how the body rids itself of damage when it is time to reproduce and create new life.

21 Sep 2011

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.

21 Sep 2011

Study reveals possible new treatment targets for diffuse intrinsic pontine gliomas

Study led by St. Jude Children's Research Hospital scientists points to possible new treatment targets for diffuse intrinsic pontine gliomas; may tip the scales in the current debate about tumor biopsies.

21 Sep 2011

Free public lecture to reveal new insights into brain cells linked with stroke, cerebral palsy

A free public lecture at the University of Leicester is to discuss how the white matter of the brain could be the key to understanding and treating brain disorders - not grey matter as previously thought.

21 Sep 2011

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Sep 2011

UTHealth doctoral student receives ASM, NIH research fellowships for E. coli study

A doctoral student at The University of Texas Health Science Center at Houston (UTHealth) has been awarded two research fellowships to study the spread of E. coli, a hard-to-treat bacterium that can lead to food poisoning.

21 Sep 2011

Researchers discover how living organisms avoid CO poisoning

Scientists have discovered how living organisms - including humans - avoid poisoning from carbon monoxide generated by natural cell processes.

From The University of Manchester 21 Sep 2011

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Bristol-Myers Squibb Company and Ono Pharmaceutical Co., Ltd., today announced an agreement to expand Bristol-Myers Squibb's territorial rights to develop and commercialize the anti-PD-1 antibody known as BMS-936558/ONO-4538, and to create a strategic alliance for the co-development and co-commercialization of ORENCIA in Japan.

21 Sep 2011

Antivirals from shark cartilage compound squalamine

A unique compound originally isolated from sharks could prove to be a promising treatment for hepatitis B and C and other viral diseases, researchers say. Known as squalamine, the drug has not yet been tested as an antiviral agent in humans, but it has been given to hundreds of people enrolled in clinical trials designed to test its usefulness for other conditions. Researchers say they hope to begin human trials to test the compound’s antiviral activity within the next year.

21 Sep 2011

Tips for recognizing stroke symptoms

Drs. Savita Khanna and Cameron Rink, both assistant professors of surgery in the College of Medicine at The Ohio State University Medical Center are part of a research team that has been working for more than a decade to identify ways to reduce brain injury during stroke.

21 Sep 2011

New blood test can help detect heart attacks

Loyola University Chicago Stritch School of Medicine researchers are reporting a possible new blood test to help diagnose heart attacks.

21 Sep 2011

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Silence Therapeutics Plc, a leading international RNAi therapeutics company, today provides a corporate update and announces its interim results for the six months ended 30 June 2011.

21 Sep 2011

MDC researchers determine molecular structure of dynamin

Dr. Katja F-lber and Professor Oliver Daumke, structural biologists at the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, together with researchers from Freie Universit-t (FU) Berlin, have determined the molecular structure of dynamin, a 'wire-puller' that mediates nutrient uptake into the cell.

21 Sep 2011

Researchers can reverse aging process for human adult stem cells

Researchers have shown they can reverse the aging process for human adult stem cells, which are responsible for helping old or damaged tissues regenerate.

21 Sep 2011

New floating microscopic device for researchers to study wide range of cellular processes

It's a bit of a challenge. But, imagine a microscopic jet vacuum cleaner, the size of a pen nib that hovers over cell surfaces without ever touching them. Then imagine that the soap in the cleaning solution is replaced with various molecules that can be selectively delivered to the cells. This gives you a sense of a new device that researchers believe will serve as a powerful tool to study the behaviour of living cells and a range of crucial cellular processes, from cancer cell formation to how neurons align themselves in the developing brain.

21 Sep 2011

Scientists discover crucial connection in skin formation

Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.

21 Sep 2011

Beta-blocker drugs may improve survival time for melanoma patients

Beta-blocker drugs, commonly used to treat high blood pressure, may also play a major role in slowing the progression of certain serious cancers, based on a new study.

21 Sep 2011

Cell News and Research

Scientists identify stress receptor that stimulates growth and migration of cancer cells

African Americans more likely than Caucasians to develop and die from lung cancer

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Researchers show how the body rids itself of damage when needed to reproduce and create new life

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

Study reveals possible new treatment targets for diffuse intrinsic pontine gliomas

Free public lecture to reveal new insights into brain cells linked with stroke, cerebral palsy

Clinical trial to evaluate TAU's stem cell technology for ALS

UTHealth doctoral student receives ASM, NIH research fellowships for E. coli study

Researchers discover how living organisms avoid CO poisoning

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Antivirals from shark cartilage compound squalamine

Tips for recognizing stroke symptoms

New blood test can help detect heart attacks

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

MDC researchers determine molecular structure of dynamin

Researchers can reverse aging process for human adult stem cells

New floating microscopic device for researchers to study wide range of cellular processes

Scientists discover crucial connection in skin formation

Beta-blocker drugs may improve survival time for melanoma patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News